Aurora Cannabis Future Growth
Future criteria checks 1/6
Aurora Cannabis's earnings are forecast to decline at 71.1% per annum while its annual revenue is expected to grow at 13.1% per year. EPS is expected to decline by 69.3% per annum. Return on equity is forecast to be 8.4% in 3 years.
Key information
-71.1%
Earnings growth rate
-69.3%
EPS growth rate
Pharmaceuticals earnings growth | 58.2% |
Revenue growth rate | 13.1% |
Future return on equity | 8.4% |
Analyst coverage | Good |
Last updated | 22 Mar 2024 |
Recent future growth updates
Recent updates
Why Aurora Cannabis' (TSE:ACB) Earnings Are Weaker Than They Seem
Feb 15Is Aurora Cannabis (TSE:ACB) Using Too Much Debt?
Sep 12Investors Holding Back On Aurora Cannabis Inc. (TSE:ACB)
Jun 13Is Aurora Cannabis (TSE:ACB) Using Debt Sensibly?
Jan 15Downgrade: Here's How Analysts See Aurora Cannabis Inc. (TSE:ACB) Performing In The Near Term
Nov 13Does Aurora Cannabis (TSE:ACB) Have A Healthy Balance Sheet?
Sep 22Aurora Cannabis (TSE:ACB) Is Carrying A Fair Bit Of Debt
Apr 21Is Aurora Cannabis (TSE:ACB) Using Too Much Debt?
Jan 05A Look At The Intrinsic Value Of Aurora Cannabis Inc. (TSE:ACB)
Nov 13Is Aurora Cannabis (TSE:ACB) Weighed On By Its Debt Load?
Oct 04Aurora Cannabis Inc. (TSE:ACB) Shares Could Be 46% Below Their Intrinsic Value Estimate
Aug 10Is Aurora Cannabis (TSE:ACB) Using Too Much Debt?
Jul 06Analysts Have Just Cut Their Aurora Cannabis Inc. (TSE:ACB) Revenue Estimates By 19%
May 15Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
3/31/2026 | 367 | 6 | 31 | 38 | 4 |
3/31/2025 | 320 | -8 | -15 | 20 | 6 |
3/31/2024 | 272 | -62 | -69 | -39 | 8 |
12/31/2023 | 276 | 411 | -99 | -83 | N/A |
9/30/2023 | 273 | 374 | -153 | -139 | N/A |
6/30/2023 | 258 | 331 | -149 | -139 | N/A |
3/31/2023 | 233 | -265 | -171 | -154 | N/A |
12/31/2022 | 212 | -1,748 | -181 | -157 | N/A |
9/30/2022 | 210 | -1,757 | -152 | -118 | N/A |
6/30/2022 | 221 | -1,718 | -142 | -110 | N/A |
3/31/2022 | 226 | -1,233 | -98 | -64 | N/A |
12/31/2021 | 231 | -381 | -122 | -82 | N/A |
9/30/2021 | 238 | -607 | -165 | -124 | N/A |
6/30/2021 | 245 | -692 | -264 | -211 | N/A |
3/31/2021 | 257 | -2,387 | -357 | -284 | N/A |
12/31/2020 | 275 | -2,359 | -430 | -285 | N/A |
9/30/2020 | 263 | -3,342 | -614 | -357 | N/A |
6/30/2020 | 269 | -3,231 | -691 | -342 | N/A |
3/31/2020 | 299 | -1,405 | -778 | -293 | N/A |
12/31/2019 | 291 | -1,430 | -787 | -289 | N/A |
9/30/2019 | 290 | -385 | -667 | -218 | N/A |
6/30/2019 | 246 | -294 | -606 | -192 | N/A |
3/31/2019 | 168 | -211 | -519 | -233 | N/A |
12/31/2018 | 119 | -72 | -439 | -206 | N/A |
9/30/2018 | 77 | 174 | -334 | -146 | N/A |
6/30/2018 | 55 | 72 | -219 | -82 | N/A |
3/31/2018 | 42 | -13 | -146 | -35 | N/A |
12/31/2017 | 31 | 7 | -91 | -16 | N/A |
9/30/2017 | 23 | -4 | N/A | -15 | N/A |
6/30/2017 | 18 | -13 | N/A | -13 | N/A |
3/31/2017 | 13 | -16 | N/A | -17 | N/A |
12/31/2016 | 8 | -13 | N/A | -11 | N/A |
9/30/2016 | 5 | -10 | N/A | -9 | N/A |
6/30/2016 | 1 | -6 | N/A | -7 | N/A |
3/31/2016 | 0 | 0 | N/A | -5 | N/A |
12/31/2015 | N/A | -3 | N/A | -3 | N/A |
9/30/2015 | N/A | -10 | N/A | -3 | N/A |
6/30/2015 | N/A | -10 | N/A | -3 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ACB's earnings are forecast to decline over the next 3 years (-71.1% per year).
Earnings vs Market: ACB's earnings are forecast to decline over the next 3 years (-71.1% per year).
High Growth Earnings: ACB's earnings are forecast to decline over the next 3 years.
Revenue vs Market: ACB's revenue (13.1% per year) is forecast to grow faster than the Canadian market (6.2% per year).
High Growth Revenue: ACB's revenue (13.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: ACB's Return on Equity is forecast to be low in 3 years time (8.4%).